Evaluation of oxidative stress in pseudo-exfoliative glaucoma patients treated with and without topical coenzyme Q10 and vitamin E

Abstract

Purpose:

To evaluate the levels of oxidative stress markers such as superoxide dismutase and malondialdehyde in eyes with pseudo-exfoliative glaucoma treated with and without topical coenzyme Q10 (CQ10) and vitamin E (Coqun drop).

Methods:

This prospective, randomized clinical study was conducted on 64 eyes of 64 patients. All patients underwent phacoemulsification and intraocular lens implantation surgery. Aqueous humor samples were aspirated from the anterior chamber at the beginning of cataract surgery. The pseudo-exfoliative glaucoma + Coqun group received topical Coqun (100 mg CQ10, 500 mg Vitamin E TPGS) twice daily for 1 month preoperatively, while the pseudo-exfoliative glaucoma group consisted of pseudo-exfoliative glaucoma cases who had not taken Coqun. Pseudo-exfoliation syndrome cases formed the pseudo-exfoliation syndrome group. The main outcomes were the superoxide dismutase and malondialdehyde levels of aqueous humor in both groups.

Results:

The mean aqueous humor superoxide dismutase level was significantly higher in the pseudo-exfoliative glaucoma group than in pseudo-exfoliative glaucoma + Coqun and pseudo-exfoliation syndrome groups (p < 0.001, p = 0.004, respectively). Also, the mean aqueous humor superoxide dismutase level was significantly lower in the pseudo-exfoliation syndrome group than in pseudo-exfoliative glaucoma + Coqun group (p = 0.009). The mean malondialdehyde levels showed no significant difference between the groups (p > 0.05 for all).

Conclusion:

Our study showed lower aqueous humor level of superoxide dismutase in pseudo-exfoliation syndrome patients compared to pseudo-exfoliative glaucoma patients. Significantly lower superoxide dismutase level was observed in pseudo-exfoliative glaucoma patients who received topical Coqun compared to pseudo-exfoliative glaucoma patients without Coqun treatment. No significant change was observed on the malondialdehyde level during 1-month follow-up period.

Keywords

Coenzyme Q10 glaucoma malondialdehyde oxidative stress superoxide dismutase

Get full access to this article

View all access options for this article.

References

Ritch

Schlotzer-Schrehardt

. Exfoliation syndrome. Surv Ophthalmol 2001; 45(4): 265–315.

Ritch

. Ocular and systemic manifestations of exfoliation syndrome. J Glaucoma 2014; 23(8 Suppl. 1): S1–S8.

Aboobakar

Johnson

Stamer

et al . Major review: exfoliation syndrome; advances in disease genetics, molecular biology, and epidemiology. Exp Eye Res 2017; 154: 88–103.

Miglior

Bertuzzi

. Relationship between intraocular pressure and glaucoma onset and progression. Curr Opin Pharmacol 2013; 13(1): 32–35.

Dursun

Vural Ozec

Aydin

et al . Total oxidative stress, paraoxonase and arylesterase levels at patients with pseudoexfoliation syndrome and pseudoexfoliative glaucoma. Int J Ophthalmol 2015; 8(5): 985–990.

Tetikoglu

Sagdik

Aktas

et al . Serum prolidase activity and oxidative stress in patients with pseudoexfoliation syndrome. Graefes Arch Clin Exp Ophthalmol 2016; 254(7): 1339–1343.

Chrysostomou

Rezania

Trounce

et al . Oxidative stress and mitochondrial dysfunction in glaucoma. Curr Opin Pharmacol 2013; 13(1): 12–15.

Tezel

. Oxidative stress in glaucomatous neurodegeneration: mechanisms and consequences. Prog Retin Eye Res 2006; 25(5): 490–513.

Pinazo-Duran

Zanon-Moreno

Gallego-Pinazo

et al . Oxidative stress and mitochondrial failure in the pathogenesis of glaucoma neurodegeneration. Prog Brain Res 2015; 220: 127–153.

10.

Ozdemir

Tolun

Gul

et al . Retinal oxidative stress induced by intraocular hypertension in rats may be ameliorated by brimonidine treatment and N-acetyl cysteine supplementation. J Glaucoma 2009; 18(9): 662–665.

11.

Negida

Menshawy

El Ashal

et al . Coenzyme Q10 for patients with Parkinson’s disease: a systematic review and meta-analysis. CNS Neurol Disord Drug Targets 2016; 15(1): 45–53.

12.

Isobe

Abe

Terayama

. Levels of reduced and oxidized coenzyme Q-10 and 8-hydroxy-2′-deoxyguanosine in the CSF of patients with Alzheimer’s disease demonstrate that mitochondrial oxidative damage and/or oxidative DNA damage contributes to the neurodegenerative process. J Neurol 2010; 257(3): 399–404.

13.

Nucci

Tartaglione

Cerulli

et al . Retinal damage caused by high intraocular pressure-induced transient ischemia is prevented by coenzyme Q10 in rat. Int Rev Neurobiol 2007; 82: 397–406.

14.

Sun

Oberley

. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988; 34(3): 497–500.

15.

Moselhy

Reid

Yousef

et al . A specific, accurate, and sensitive measure of total plasma malondialdehyde by HPLC. J Lipid Res 2013; 54(3): 852–858.

16.

Osborne

del Olmo-Aguado

. Maintenance of retinal ganglion cell mitochondrial functions as a neuroprotective strategy in glaucoma. Curr Opin Pharmacol 2013; 13(1): 16–22.

17.

Ferreira

Lerner

Brunzini

et al . Antioxidant status in the aqueous humour of patients with glaucoma associated with exfoliation syndrome. Eye 2009; 23(8): 1691–1697.

18.

Erdurmus

Yagci

Atis

et al . Antioxidant status and oxidative stress in primary open angle glaucoma and pseudoexfoliative glaucoma. Curr Eye Res 2011; 36(8): 713–718.

19.

Goyal

Srivastava

Sihota

et al . Evaluation of oxidative stress markers in aqueous humor of primary open angle glaucoma and primary angle closure glaucoma patients. Curr Eye Res 2014; 39(8): 823–829.

20.

Simavli

Tosun

Bucak

et al . Serum and aqueous xanthine oxidase levels, and mRNA expression in anterior lens epithelial cells in pseudoexfoliation. Graefes Arch Clin Exp Ophthalmol 2015; 253(7): 1161–1167.

21.

Nakajima

Inokuchi

Nishi

et al . Coenzyme Q10 protects retinal cells against oxidative stress in vitro and in vivo. Brain Res 2008; 1226: 226–233.

22.

Lee

Shim

Kim

et al . Coenzyme Q10 inhibits glutamate excitotoxicity and oxidative stress-mediated mitochondrial alteration in a mouse model of glaucoma. Invest Ophthalmol Vis Sci 2014; 55(2): 993–1005.

23.

Noh

Kim

Shim

et al . Inhibition of oxidative stress by coenzyme Q10 increases mitochondrial mass and improves bioenergetic function in optic nerve head astrocytes. Cell Death Dis 2013; 4: e820.

24.

Peng

Hsu

et al . Dietary deficiency of vitamin E aggravates retinal ganglion cell death in experimental glaucoma of rats. Curr Eye Res 2010; 35(9): 842–849.

25.

Lulli

Witort

Papucci

et al . Coenzyme Q10 instilled as eye drops on the cornea reaches the retina and protects retinal layers from apoptosis in a mouse model of kainate-induced retinal damage. Invest Ophthalmol Vis Sci 2012; 53(13): 8295–8302.

26.

Fato

Bergamini

Leoni

et al . Coenzyme Q10 vitreous levels after administration of coenzyme Q10 eyedrops in patients undergoing vitrectomy. Acta Ophthalmol 2010; 88(4): e150–111.

27.

Parisi

Centofanti

Gandolfi

et al . Effects of coenzyme Q10 in conjunction with vitamin E on retinal-evoked and cortical-evoked responses in patients with open-angle glaucoma. J Glaucoma 2014; 23(6): 391–404.

28.

Nucci

Di Pierro

Varesi

et al . Increased malondialdehyde concentration and reduced total antioxidant capacity in aqueous humor and blood samples from patients with glaucoma. Mol Vis 2013; 19: 1841–1846.

29.

Mumcu

Kocer

Ates

et al . Decreased paraoxonase1 activity and increased malondialdehyde and oxidative DNA damage levels in primary open angle glaucoma. Int J Ophthalmol 2016; 9(10): 1518–1520.

30.

Kaur

Kukreja

Kaur

et al . The oxidative stress in cataract patients. J Clin Diagn Res 2012; 6(10): 1629–1632.

31.

Lian

Cao

et al . Malonaldehyde, superoxide dismutase and human cataract. Yan Ke Xue Bao 1993; 9(4): 18670–18679.

32.

Rokicki

Zalejska-Fiolka

Pojda-Wilczek

et al . Differences in serum oxidative status between glaucomatous and nonglaucomatous cataract patients. BMC Ophthalmol 2017; 17(1): 13.